| Local |
BNF | Section |
| Abemaciclib | Abemaciclib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Acalabrutinib | Acalabrutinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Afatinib | Afatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Alectinib | Alectinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Alpelisib | Alpelisib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Asciminib | Asciminib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Avapritinib | Avapritinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Axitinib | Axitinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Binimetinib | Binimetinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Bosutinib | Bosutinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Brigatinib | Brigatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Cabozantinib | Cabozantinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Capivasertib | Capivasertib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Ceritinib | Ceritinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Cobimetinib | Cobimetinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Crizotinib | Crizotinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Dabrafenib | Dabrafenib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Dacomitinib | Dacomitinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Dasatinib | Dasatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Encorafenib | Encorafenib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Entrectinib | Entrectinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Erdafitinib | Erdafitinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Erlotinib | Erlotinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Everolimus | Everolimus | Immune System, Immune System Disorders And Transplantation, Antineoplastic Drugs Protein Kinase Inhibitors |
| Everolimus | Everolimus | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Fedratinib | Fedratinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Fruquintinib | Fruquintinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Futibatinib | Futibatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy |
| Gefitinib | Gefitinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Gilteritinib | Gilteritinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Ibrutinib | Ibrutinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Idelalisib | Idelalisib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Imatinib | Imatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Lapatinib | Lapatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Larotrectinib | Larotrectinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Lenvatinib | Lenvatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Lorlatinib | Lorlatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Midostaurin | Midostaurin [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Mobocertinib | Mobocertinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Momelotinib | Momelotinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Neratinib | Neratinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Nilotinib | Nilotinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Nintedanib | Nintedanib | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Nintedanib | Nintedanib | Respiratory System, Interstitial Lung Disease, Antineoplastic Drugs Protein Kinase Inhibitors |
| Osimertinib | Osimertinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Palbociclib | Palbociclib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Pazopanib | Pazopanib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Pemigatinib | Pemigatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Ponatinib | Ponatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Pralsetinib | Pralsetinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Quizartinib | Quizartinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Regorafenib | Regorafenib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Ribociclib | Ribociclib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Ripretinib | Ripretinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Ruxolitinib | Ruxolitinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Selpercatinib | Selpercatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Sirolimus | Sirolimus | Skin, Benign Neoplasms Of Skin, Calcineurin Inhibitors And Related Drugs Protein Kinase Inhibitors |
| Sorafenib | Sorafenib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Sunitinib | Sunitinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Temsirolimus | Temsirolimus [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Tepotinib | Tepotinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Tirbanibulin | Tirbanibulin | Skin, Sun Protection And Photodamage, Antineoplastic Drugs Protein Kinase Inhibitors |
| Tivozanib | Tivozanib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Trametinib | Trametinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Tucatinib | Tucatinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Vandetanib | Vandetanib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Vemurafenib | Vemurafenib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |
| Zanubrutinib | Zanubrutinib [Specialist Drug] | Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors |